DEA safety document
This article was originally published in The Rose Sheet
Executive Summary
National Toxicity Program releases background documents for four nominations under consideration for inclusion in the 11th "Report on Carcinogens," including diethanolamine, according to a notice published in the May 24 1Federal Register. Documents are available through the NTP Web site at 2http://ntp-server.niehs.nih.gov. CTFA asserted in Sept. 17, 2001 comments to NTP that existing test data on DEA do not meet NTP criteria for determining ingredients are "reasonably anticipated to be" human carcinogens (3"The Rose Sheet" Oct. 1, 2001, p. 8). Background documents for other nominations including cobalt sulfate, nitromethane and 4, 4-thiodianiline also now available...
You may also be interested in...
DEA Cosmetics Use, Carcinogenicity Potential Explored In NTP Report
Consumer exposure to diethanolamine appears to be widespread with dermal exposure to personal care products serving as the "most probable route," the National Toxicology Program states in a background draft document for the 11th "Report on Carcinogens.
DEA Carcinogenicity Evidence Limited To "One Study, One Species" - CTFA
Animal data indicating diethanolamine may be a human carcinogen are limited to "one study in one species, with...one route of exposure," the Cosmetic, Toiletry and Fragrance Association maintains in Sept. 17 comments to the National Toxicology Program.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”